Inotek closes second venture round with an additional $10 million

Inotek Pharmaceuticals of Beverly, MA, has rounded up a second tranche of $10 million, bringing the total to $35 million. New investors included Canada's Caisse de depot et placement du Quebec and Israel's Pitango Venture Capital.

- read this report from MassHighTech for more

PLUS: QuadraSpec, a protein-diagnostics firm in West Lafayette, IN, has raised $3.9 million in its first round. Release